PapersPMID:38570276
Berberine inhibits NLRP3 inflammasome activation and proinflammatory macrophage M1 polarization to accelerate peripheral nerve regeneration.
What moved
1 findingHow to read these marks →- Inhibits NLRP3
insufficient
“The qRT-PCR results showed that BBR dose-dependently inhibited the mRNA expression of NLRP3 and its linked molecules, including IL-1β, caspase-1, ASC, and GSDMAD.”
- Study
- animal · not in humans
- Duration
- 4 weeks
- Dose studied
- 60-240 mg/kg/day, daily oral gavage, days 1-28
- Population
- C57BL/6J mice with sciatic nerve crush injury (peripheral nerve injury), injury-site tissue
Study record
- Design
- animal study, in vivo
- Species
- animal / mixed
- Population
- C57BL/6J mice, male and female, sciatic nerve crush (peripheral nerve injury) model
- Participants
- not reported
- Comparator
- another dose
- Duration
- 28 days
- Endpoints measured
- 6
berberine